Application 017588
- Type
- NDA
- Sponsor
- CORDEN PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GLEOSTINE | LOMUSTINE | CAPSULE;ORAL | 10MG | Yes | No |
| 002 | GLEOSTINE | LOMUSTINE | CAPSULE;ORAL | 40MG | Yes | No |
| 003 | GLEOSTINE | LOMUSTINE | CAPSULE;ORAL | 100MG | Yes | Yes |
| 004 | GLEOSTINE | LOMUSTINE | CAPSULE;ORAL | 5MG | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N017588-001 | GLEOSTINE | LOMUSTINE | 10MG | CAPSULE / ORAL | AB | RLD, Approved before 1982 | |
| N017588-002 | GLEOSTINE | LOMUSTINE | 40MG | CAPSULE / ORAL | AB | RLD, RS, Approved before 1982 | |
| N017588-003 | GLEOSTINE | LOMUSTINE | 100MG | CAPSULE / ORAL | AB | RLD, Approved before 1982 | |
| N017588-004 | GLEOSTINE | LOMUSTINE | 5MG | CAPSULE / ORAL | RLD | 2014-12-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N017588-001 | AB |
| N017588-002 | AB |
| N017588-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-07-19 19:46 UTC | 2019-07 | N017588-001 | GLEOSTINE | 10MG | CAPSULE / ORAL | RLD, Approved before 1982 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N017588-002 | GLEOSTINE | 40MG | CAPSULE / ORAL | RLD, Approved before 1982 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N017588-003 | GLEOSTINE | 100MG | CAPSULE / ORAL | RLD, RS, Approved before 1982 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N017588-004 | GLEOSTINE | 5MG | CAPSULE / ORAL | RLD | 2014-12-19 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N017588-001 | GLEOSTINE | 10MG | CAPSULE / ORAL | RLD, Approved before 1982 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N017588-002 | GLEOSTINE | 40MG | CAPSULE / ORAL | RLD, Approved before 1982 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N017588-003 | GLEOSTINE | 100MG | CAPSULE / ORAL | RLD, RS, Approved before 1982 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N017588-004 | GLEOSTINE | 5MG | CAPSULE / ORAL | RLD | 2014-12-19 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N017588-001 | GLEOSTINE | 10MG | CAPSULE / ORAL | RLD, Approved before 1982 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | N017588-002 | GLEOSTINE | 40MG | CAPSULE / ORAL | RLD, Approved before 1982 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | N017588-003 | GLEOSTINE | 100MG | CAPSULE / ORAL | RLD, RS, Approved before 1982 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | N017588-004 | GLEOSTINE | 5MG | CAPSULE / ORAL | RLD | 2014-12-19 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N017588-001 | GLEOSTINE | 10MG | CAPSULE / ORAL | RLD, Approved before 1982 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | N017588-002 | GLEOSTINE | 40MG | CAPSULE / ORAL | RLD, Approved before 1982 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | N017588-003 | GLEOSTINE | 100MG | CAPSULE / ORAL | RLD, RS, Approved before 1982 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | N017588-004 | GLEOSTINE | 5MG | CAPSULE / ORAL | RLD | 2014-12-19 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N017588-001 | GLEOSTINE | 10MG | CAPSULE / ORAL | RLD, Approved before 1982 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N017588-002 | GLEOSTINE | 40MG | CAPSULE / ORAL | RLD, Approved before 1982 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N017588-003 | GLEOSTINE | 100MG | CAPSULE / ORAL | RLD, RS, Approved before 1982 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N017588-004 | GLEOSTINE | 5MG | CAPSULE / ORAL | RLD | 2014-12-19 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N017588-001 | GLEOSTINE | 10MG | CAPSULE / ORAL | RLD, Approved before 1982 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N017588-002 | GLEOSTINE | 40MG | CAPSULE / ORAL | RLD, Approved before 1982 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N017588-003 | GLEOSTINE | 100MG | CAPSULE / ORAL | RLD, RS, Approved before 1982 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N017588-004 | GLEOSTINE | 5MG | CAPSULE / ORAL | RLD | 2014-12-19 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N017588-001 | GLEOSTINE | 10MG | CAPSULE / ORAL | RLD, Approved before 1982 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N017588-002 | GLEOSTINE | 40MG | CAPSULE / ORAL | RLD, Approved before 1982 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N017588-003 | GLEOSTINE | 100MG | CAPSULE / ORAL | RLD, RS, Approved before 1982 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N017588-004 | GLEOSTINE | 5MG | CAPSULE / ORAL | RLD | 2014-12-19 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N017588-001 | GLEOSTINE | 10MG | CAPSULE / ORAL | RLD, Approved before 1982 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N017588-002 | GLEOSTINE | 40MG | CAPSULE / ORAL | RLD, Approved before 1982 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N017588-003 | GLEOSTINE | 100MG | CAPSULE / ORAL | RLD, RS, Approved before 1982 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N017588-004 | GLEOSTINE | 5MG | CAPSULE / ORAL | RLD | 2014-12-19 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N017588-001 | GLEOSTINE | 10MG | CAPSULE / ORAL | RLD, Approved before 1982 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | N017588-002 | GLEOSTINE | 40MG | CAPSULE / ORAL | RLD, Approved before 1982 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | N017588-003 | GLEOSTINE | 100MG | CAPSULE / ORAL | RLD, RS, Approved before 1982 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | N017588-004 | GLEOSTINE | 5MG | CAPSULE / ORAL | RLD | 2014-12-19 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N017588-001 | GLEOSTINE | 10MG | CAPSULE / ORAL | RLD, Approved before 1982 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | N017588-002 | GLEOSTINE | 40MG | CAPSULE / ORAL | RLD, Approved before 1982 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | N017588-003 | GLEOSTINE | 100MG | CAPSULE / ORAL | RLD, RS, Approved before 1982 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | N017588-004 | GLEOSTINE | 5MG | CAPSULE / ORAL | RLD | 2014-12-19 | 3bdfa0b2c4d7… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N017588-001 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N017588-002 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N017588-003 | AB | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | N017588-001 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N017588-002 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N017588-003 | AB | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | N017588-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N017588-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N017588-003 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N017588-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N017588-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N017588-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N017588-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N017588-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N017588-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N017588-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N017588-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N017588-003 | AB | 1 | 31067a03dcf5… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N017588-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N017588-002 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N017588-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lomustine | LOMUSTINE | Wilshire Pharmaceuticals, Inc. | 3c3637fc-4499-4331-a3c4-6969fc86704e | 2026-02-12 | Boxed warning, Warnings, Adverse reactions | 017588 NDA017588 |
| Gleostine | LOMUSTINE | Azurity Pharmaceuticals, Inc. | 3529fe2f-3c23-4862-bb20-b48026957082 | 2025-09-25 | Boxed warning, Warnings, Adverse reactions | 017588 NDA017588 |
| Gleostine | LOMUSTINE | NextSource Biotechnology, LLC | 7f77526b-4c40-409c-82ea-d0f934d89cc2 | 2024-01-23 | Boxed warning, Warnings, Adverse reactions | 017588 NDA017588 58181-3040 58181-3042 58181-3041 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 58181-3040 | Gleostine | lomustine | NextSource Biotechnology, LLC | NDA | Current |
| 58181-3040 | Gleostine | lomustine | NextSource Biotechnology, LLC | NDA | Current |
| 58181-3040 | Gleostine | lomustine | NextSource Biotechnology, LLC | NDA | Current |
| 58181-3041 | Gleostine | lomustine | NextSource Biotechnology, LLC | NDA | Current |
| 58181-3041 | Gleostine | lomustine | NextSource Biotechnology, LLC | NDA | Current |
| 58181-3041 | Gleostine | lomustine | NextSource Biotechnology, LLC | NDA | Current |
| 58181-3042 | Gleostine | lomustine | NextSource Biotechnology, LLC | NDA | Current |
| 58181-3042 | Gleostine | lomustine | NextSource Biotechnology, LLC | NDA | Current |
| 58181-3042 | Gleostine | lomustine | NextSource Biotechnology, LLC | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 64854 | SUPPL | 2020-10-06 |
| 63588 | SUPPL | 2020-06-17 |
| 33317 | SUPPL | 2016-02-02 |
| 13864 | SUPPL | 2016-02-01 |
| 11042 | SUPPL | 2016-01-07 |
| 661 | SUPPL | 2016-01-07 |
| 33316 | SUPPL | 2014-05-28 |
| 660 | SUPPL | 2014-05-22 |
| 11041 | SUPPL | 2013-08-21 |
| 11040 | SUPPL | 2012-11-28 |
| 658 | SUPPL | 2012-11-23 |
| 33315 | SUPPL | 2011-05-16 |
| 659 | SUPPL | 2011-05-16 |
| 33314 | SUPPL | 2009-05-11 |
| 657 | SUPPL | 2009-05-06 |
| 656 | SUPPL | 2003-03-10 |
| 655 | SUPPL | 2002-12-20 |